Latest Breaking News On - Kang therapeutics - Page 1 : comparemela.com

NiKang Therapeutics Presents the Discovery and Unique Mechanism of Action of a Selective CDK2 Inhibitor NKT3447 at AACR Annual Meeting 2024

NiKang Therapeutics Inc. ("NiKang"), a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, announced today the unveiling of NKT3447 at the American Association.

United statesZhenhai gaoNikang therapeutics incAmerican association for cancer researchProduct serviceKang therapeutics presentsUnique mechanismKang therapeuticsAmerican associationCancer researchAnnual meetingPresentation detailsCell cycle proteins

Rx Rundown: Novartis, Goldman Sachs, Klick Health and more

Check out this week’s medical marketing news, people on the move and industry chatter.

United statesCity ofUnited kingdomPaulette mccarronAstellas pharmaAmy zachariasYonatan adiriEli lillyDudley bakerTim jonesPaul ginesteGeoff martinVerona pharmaAdam friedmanPaddi hurleyEvan bograd

NiKang Therapeutics Appoints Joanne Lager, M D , as Chief Medical Officer

NiKang Therapeutics Appoints Joanne Lager, M D , as Chief Medical Officer
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Zhenhai gaoJoanne jo lagerJoanne lagerNikang therapeutics incHead of global oncology development at sanofiKang therapeutics appoints joanne lagerChief medicalKang therapeuticsChief medical officerChief executive officerTeos therapeuticsGlobal oncology development

NiKang Therapeutics Enters into Clinical Trial Collaboration and Supply Agreement to Evaluate NKT2152 in Combination with Standard-of-Care in First-Line Advanced Hepatocellular Carcinoma

NiKang Therapeutics Enters into Clinical Trial Collaboration and Supply Agreement to Evaluate NKT2152 in Combination with Standard-of-Care in First-Line Advanced Hepatocellular Carcinoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kelsey chenZhenhai gaoNikang therapeutics incRoche ltdKang therapeuticsRenal cell carcinomaOperating officerNikang therapeutics

Wilmington-area pharma start-up NiKang secures $200 million in financing

Delaware-based NiKang Therapeutics Inc. completed an oversubscribed $200 million series C financing. Last year, the company received $50 million in series B financing. “We are thrilled to have such an outstanding group of investors as our shareholders” said Zhenhai Gao, CEO of NiKang. “Their

United statesKelsey chenZhenhai gaoReading timeKang therapeuticsDelaware innovation spaceInnovation spaceஒன்றுபட்டது மாநிலங்களில்கெல்ஸீ சென்ரீடிஂக் நேரம்காங் சிகிச்சைடெலாவேர் கண்டுபிடிப்பு இடம்கண்டுபிடிப்பு இடம்